🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This study examines the use of patient initiated discussions of blood press...
Status
Completed
Location
VA Medical Center, Iowa City
Start Date
2006-07
Trial ID
NCT00265538
Using a randomized clinical trial (RCT), this study is designed to assess t...
Status
Completed
Location
NGO
Start Date
2010-07
Trial ID
NCT01159704
Treatments Being Tested
This study aimed to examine the effect of the "I Am Protecting My Child fro...
Status
Completed
Location
Akdeniz University, Kumluca Faculty of Health Sciences
Start Date
2018-04-01
Trial ID
NCT04251598
Treatments Being Tested
This study will use Magnetic Resonance Imaging (MRI) to study the lungs of ...
Status
Terminated
Location
Hospital of the University of Pennsylvania
Start Date
2021-01-19
Trial ID
NCT04941573
Treatments Being Tested
This research project will contribute to the research surrounding the effec...
Status
Completed
Location
St Mary's Hospital
Start Date
2020-01-01
Trial ID
NCT03878875
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
In literature, it has been reported that exercise capacity decreases in sin...
Status
Completed
Location
Hacettepe University
Start Date
2021-09-20
Trial ID
NCT05063903
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested